Effects of L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts

Effects of L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts

Show other versions (1)

Bibliographic Details
Main Authors:	Yip, B, Pellagatti, A, Vuppusetty, C, Giagounidis, A, Germing, U, Lamikanra, A, Roberts, D, Fernandez-Mercado, M, McDonald, E, Killick, S, Wainscoat, J, Boultwood, J
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
by: Yip, B, et al.
Published: (2012)

Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
by: Yip, B, et al.
Published: (2013)

Activation of the mTOR signaling pathway by L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
by: Yip, B, et al.
Published: (2013)

Activation of the mTOR Signaling Pathway by L-Leucine in RPS14-Deficient Erythroid Cells
by: Yip, B, et al.
Published: (2012)

L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients
by: Bello, E, et al.
Published: (2018)

Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.
by: Boultwood, J, et al.
Published: (2013)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
by: Pellagatti, A, et al.
Published: (2008)

Haploinsufficiency of RPS14 and Deregulation of Ribosomal- and Translation-Related Genes in MDS Patients with Del(5q)
by: Pellagati, A, et al.
Published: (2008)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes (British Journal of Haematology (2008) 142, (57-64))
by: Pellagatti, A, et al.
Published: (2009)

The 5q- syndrome.
by: Giagounidis, A, et al.
Published: (2004)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
by: Fernandez-Mercado, M, et al.
Published: (2013)

The role of haploinsufficiency of RPS14 and p53 activation in the molecular pathogenesis of the 5q- syndrome.
by: Boultwood, J
Published: (2011)

Gene expression profiling of day 7 erythroblasts from RARS before and after treatment with G-CSF
by: Nikpour, M, et al.
Published: (2007)

5q- syndrome.
by: Boultwood, J, et al.
Published: (2012)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
by: Pellagatti, A, et al.
Published: (2005)

Advances in the 5q- syndrome.
by: Boultwood, J, et al.
Published: (2010)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q).
by: Pellagatti, A, et al.
Published: (2004)

GENE COMPARISON STUDIES OF ERYTHROBLASTS DERIVED FROM DIFFERENT HAEMATOPOIETIC SOURCES
by: Merryweather-Clarke, A, et al.
Published: (2013)

Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G-CSF.
by: Nikpour, M, et al.
Published: (2010)

Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome.
by: Boultwood, J, et al.
Published: (2012)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia
by: Pellagatti, A, et al.
Published: (2014)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia.
by: Pellagatti, A, et al.
Published: (2014)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
by: Pellagatti, A, et al.
Published: (2011)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
by: Pellagatti, A, et al.
Published: (2011)

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
by: Boultwood, J, et al.
Published: (2007)

Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density SNP arrays
by: Wang, L, et al.
Published: (2007)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
by: Fernandez-Mercado, M, et al.
Published: (2010)

Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome.
by: Pellagatti, A, et al.
Published: (2010)

Aberrant Expression of DOCK4 Leads to Disruption of the F-Actin Skeleton and Altered Membrane Stability in MDS Erythroblasts and Mature Erythrocytes
by: Sundaravel, S, et al.
Published: (2012)

Aberrant Expression of DOCK4 Leads to Disruption of the F-Actin Skeleton and Altered Membrane Stability in MDS Erythroblasts and Mature Erythrocytes
by: Sundaravel, S, et al.
Published: (2012)

Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets
by: Nikpour, M, et al.
Published: (2009)

The 5q-syndrome.
by: Boultwood, J, et al.
Published: (1994)

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridisation (CGH)
by: Esoof, N, et al.
Published: (2005)

YI1 Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets
by: Nikpour, M, et al.
Published: (2009)

Scalable in vitro production of defined mouse erythroblasts
by: Francis, HS, et al.
Published: (2022)

Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics
by: Fernandez-Mercado, M, et al.
Published: (2012)

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
by: Wang, L, et al.
Published: (2008)

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridization (CGH).
by: Esoof, N, et al.
Published: (2006)

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells
by: Davies, C, et al.
Published: (2013)

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34⁺ progenitor cells.
by: Davies, C, et al.
Published: (2013)